Paul Tudor Jones’s AbbVie ABBV Stock Holding History

Paul Tudor Jones’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.3M	Buy	215,900 +27,300	+14%	+$5.87M	0.08%	194
2026 Q1	$41M	Buy	188,600 +97,600	+107%	+$21.7M	0.08%	189
2025 Q4	$20.8M	Sell	91,000 -102,700	-53%	-$23.4M	0.04%	404
2025 Q3	$44.8M	Buy	193,700 +186,900	+2,749%	+$38.1M	0.08%	194
2025 Q2	$1.26M	Buy	+6,800	New	+$1.26M	﹤0.01%	1980
2024 Q3	–	Sell	-1,200	Closed	-$206K	–	2640
2024 Q2	$206K	Buy	+1,200	New	+$199K	﹤0.01%	2156
2024 Q1	–	Sell	-70,900	Closed	-$11M	–	2152
2023 Q4	$11M	Buy	+70,900	New	+$10.3M	0.09%	310

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paul Tudor Jones's ABBV Position: Q2 2026 in Review

Paul Tudor Jones sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 161,053 shares — an estimated $34.6M sold.

Paul Tudor Jones first reported a position in ABBV in Q2 2013 and held it in 34 quarters. The position peaked at $61.4M in Q2 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Paul Tudor Jones reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 161,053 AbbVie shares in Q2 2026, an estimated $34.6M.
Paul Tudor Jones first reported a position in AbbVie in Q2 2013 and held it in 34 quarters.
Paul Tudor Jones's AbbVie position peaked at $61.4M in Q2 2025.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.